DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Kopylov U, Afif W, Cohen A. et al.
Subcutaneous ustekinumab for the treatment of anti-TNF resistant Crohnʼs disease--the McGill experience.
J Crohns Colitis 2014;
8: 1516-1522
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.